TB Vaccine Brings New Hope to Multiple Sclerosis Patients
This week, the AAPS blog reveals new research on treatment for multiple sclerosis. The blog post, TB Vaccine Brings New Hope to Multiple Sclerosis Patients discusses how tuberculosis vaccine actually staves off the disease in patients with early warning signs. Early detection and treatment is crucial because once advanced, MS strips patients of their mobility. According to the blog post,
The disease develops when the nerves of the brain and the spinal cord are damaged by one’s own immune system. The ultimate result is paralysis, vision loss, and diminished brain function. Not only is MS physically and emotionally devastating, treatment comes with a hefty price tag. In the US, one year of therapy rings in at around $50,000.
Bringing a ray of hope to MS sufferers, clinical research has revealed that a tuberculosis vaccine may help prevent the development of MS in patients with early symptoms. It’s an exciting alternative therapy for the many patients unable to afford prohibitively pricey drugs.
For patients with no medical insurance, $50,000 a year in MS therapy may simply not be an option. Is this another case of Big Pharma putting profits before patients? Unfortunately, up until now, there has been little hope for cheaper alternatives. Although still in the early stages of study, the TB vaccine may be just the solution needed to democratize access to MS treatment and actually beat the disease before it advances beyond repair.